Net Cash Provided by (Used in) Operating Activities |
4K |
USD |
|
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
2.7M |
USD |
|
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
1K |
shares |
|
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
1K |
shares |
|
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
2.7M |
USD |
|
Q1 2025 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
787K |
USD |
+9738% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
803K |
USD |
+1015% |
Q2 2025 |
Q2 2025 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.8 |
pure |
|
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
675K |
USD |
+838% |
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
2.96M |
USD |
|
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
803K |
USD |
+1015% |
Q2 2025 |
Q2 2025 |